Gf Fund Management Co. Ltd. Ionis Pharmaceuticals Inc Transaction History
Gf Fund Management Co. Ltd.
- $4.26 Trillion
- Q1 2025
A detailed history of Gf Fund Management Co. Ltd. transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Gf Fund Management Co. Ltd. holds 4,042 shares of IONS stock, worth $152,262. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,042
Previous 3,315
21.93%
Holding current value
$152,262
Previous $116 Million
5.22%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding IONS
# of Institutions
400Shares Held
145MCall Options Held
916KPut Options Held
552K-
Vanguard Group Inc Valley Forge, PA16.4MShares$617 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD16.2MShares$609 Million0.32% of portfolio
-
Capital World Investors Los Angeles, CA12.4MShares$466 Million0.06% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$389 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA8.42MShares$317 Million0.05% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $5.35B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...